These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 8844806)
21. Acetyltransferase and sulfotransferase which activate mutagens and carcinogens through O-esterification mechanisms. Yamazoe Y; Abu-Zeid M; Gong DW; Ozawa S; Nagata K; Kato R Princess Takamatsu Symp; 1990; 21():109-17. PubMed ID: 2134670 [TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Ozawa S; Tang YM; Yamazoe Y; Kato R; Lang NP; Kadlubar FF Chem Biol Interact; 1998 Feb; 109(1-3):237-48. PubMed ID: 9566748 [TBL] [Abstract][Full Text] [Related]
23. Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines. McKinnon RA; McManus ME Princess Takamatsu Symp; 1995; 23():145-53. PubMed ID: 8844805 [TBL] [Abstract][Full Text] [Related]
24. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative. King RS; Teitel CH; Shaddock JG; Casciano DA; Kadlubar FF Cancer Lett; 1999 Sep; 143(2):167-71. PubMed ID: 10503898 [TBL] [Abstract][Full Text] [Related]
25. Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. Kato R Crit Rev Toxicol; 1986; 16(4):307-48. PubMed ID: 3519087 [TBL] [Abstract][Full Text] [Related]
26. Binding of heterocyclic amines by lactic acid bacteria from miso, a fermented Japanese food. Rajendran R; Ohta Y Can J Microbiol; 1998 Feb; 44(2):109-15. PubMed ID: 9543712 [TBL] [Abstract][Full Text] [Related]
27. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Hein DW; Rustan TD; Ferguson RJ; Doll MA; Gray K Arch Toxicol; 1994; 68(2):129-33. PubMed ID: 8179482 [TBL] [Abstract][Full Text] [Related]
28. Screening of molecular cell targets for carcinogenic heterocyclic aromatic amines by using CALUX® reporter gene assays. Steinberg P; Behnisch PA; Besselink H; Brouwer AA Cell Biol Toxicol; 2017 Jun; 33(3):283-293. PubMed ID: 27942899 [TBL] [Abstract][Full Text] [Related]
29. Activation and effects of the food-derived heterocyclic amines in extrahepatic tissues. Overvik E; Hellmold H; Branting C; Gustafsson JA Princess Takamatsu Symp; 1995; 23():123-33. PubMed ID: 8844803 [TBL] [Abstract][Full Text] [Related]
30. Metabolic activation of methyl-hydroxylated derivatives of 7,12-dimethylbenz[a]anthracene by human liver dehydroepiandrosterone-steroid sulfotransferase. Chou HC; Ozawa S; Fu PP; Lang NP; Kadlubar FF Carcinogenesis; 1998 Jun; 19(6):1071-6. PubMed ID: 9667746 [TBL] [Abstract][Full Text] [Related]
32. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2. Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues. Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Hammons GJ; Milton D; Stepps K; Guengerich FP; Tukey RH; Kadlubar FF Carcinogenesis; 1997 Apr; 18(4):851-4. PubMed ID: 9111224 [TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon. Nozawa H; Tazumi K; Sato K; Yoshida A; Takata J; Arimoto-Kobayashi S; Kondo K Mutat Res; 2004 Apr; 559(1-2):177-87. PubMed ID: 15066585 [TBL] [Abstract][Full Text] [Related]
36. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates. Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797 [TBL] [Abstract][Full Text] [Related]
37. N-hydroxylation of carcinogenic and mutagenic aromatic amines. Kato R; Kamataki T; Yamazoe Y Environ Health Perspect; 1983 Mar; 49():21-5. PubMed ID: 6832094 [TBL] [Abstract][Full Text] [Related]
38. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Lin D; Meyer DJ; Ketterer B; Lang NP; Kadlubar FF Cancer Res; 1994 Sep; 54(18):4920-6. PubMed ID: 8069858 [TBL] [Abstract][Full Text] [Related]
39. Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines. Gorlewska-Roberts KM; Teitel CH; Lay JO; Roberts DW; Kadlubar FF Chem Res Toxicol; 2004 Dec; 17(12):1659-66. PubMed ID: 15606142 [TBL] [Abstract][Full Text] [Related]
40. Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4, 5-f]quinoline. Agus C; Ilett KF; Kadlubar FF; Minchin RF Carcinogenesis; 2000 Jun; 21(6):1213-9. PubMed ID: 10837012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]